ADAaron S. Dumont

Aaron S. Dumont

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aaron S. Dumont has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Neal F. Kassell

    5 shared publications
  • Randall J. Dumont

    Department of Neurological Surgery, University of Virginia School of Medicine, Charlottesville, Virginia, and Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

    4 shared publications
  • Subodh Verma

    Division of Cardiac Surgery, University of Toronto, Toronto, Ontario, Canada

    4 shared publications
  • Garnette R. Sutherland

    Division of Neurosurgery, University of Calgary, Calgary, Alberta, Canada

    3 shared publications
  • John H. McNeill

    Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada

    2 shared publications
  • Michael M. Chow

    Department of Neurological Surgery, University of Virginia School of Medicine, Charlottesville, Virginia

    2 shared publications

Latest Publications

  • Endovascular Treatment or Neurosurgical Clipping of Ruptured Intracranial Aneurysms

    by Aaron S. Dumont, R. Webster Crowley, Stephen J. Monteith, Don Ilodigwe, Neal F. Kassell, Stephan Mayer, Daniel Ruefenacht, Stephan Weidauer, Alberto Pasqualin, R. Loch Macdonald

    Background and Purpose— The effects of aneurysm treatment modality (clipping or coiling) on the incidence of cerebral vasospasm and infarction after subarachnoid hemorrhage have not been clearly defined. We hypothesized that there may be a difference in angiographic and clinical vasospasm, cerebral infarction, and clinical outcome between patients undergoing clipping compared to coiling. Methods— A retrospective, exploratory analysis of 413 patients randomized into the CONSCIOUS-1 trial was conducted. Patients underwent baseline and follow-up catheter angiography and computed tomography, as well as clinical assessments. Radiology end points were adjudicated by central blinded review, and angiographic vasospasm was quantified by measurements of arterial diameters on catheter angiography. The effect of method of aneurysm treatment (clipping [n=199] or coiling [n=214]) on angiographic vasospasm, delayed ischemic neurological deficit, cerebral infarction, and clinical outcome was analyzed using univariate and multivariate logistic regression. Propensity matching was used to adjust for differences in baseline risk factors between clipped and coiled patients. Results— In all patients and the propensity-matched subset, aneurysm coiling was associated with a significantly reduced risk of angiographic vasospasm and delayed ischemic neurological deficit compared to clipping. Cerebral infarction and clinical outcome were not associated with clipping or coiling. Conclusions— In this exploratory analysis, aneurysm coiling was associated with less angiographic vasospasm and delayed ischemic neurological deficit than surgical clipping, whereas no effect on cerebral infarction or clinical outcome was observed. Whether this is attributable to differences in baseline risk factors between clipped and coiled patients or a true difference cannot be proven here.


  • Evolution of cerebral revascularization techniques

    by R. Webster Crowley, Ricky Medel, Aaron S. Dumont

    ✓As a leading cause of death and disability in patients across the world, stroke is a problem that plagues both neurosurgeons and neurologists alike. Whether a result of atherosclerosis, moyamoya disease, or a complication in the treatment of a complex intracranial aneurysm, cerebrovascular occlusion can have devastating effects on patients. For nearly half a century neurosurgeons have searched for safer, more effective ways to increase the amount of blood flow to ischemic brain tissue. From the first extracranial–intracranial bypasses to the recent technological advancements seen with endovascular therapy, cerebral revascularization techniques have been constantly evolving. Over the years cerebral ischemia has gone from a condition that was previously considered surgically untreatable, to a condition with several viable options for prevention and treatment. In this paper the authors discuss the historical evolution of treatment for cerebrovascular occlusive disease.


  • Open Access

    Cerebral Vasospasm after Subarachnoid Hemorrhage: Putative Role of Inflammation

    by Aaron S. Dumont, Randall J. Dumont, Michael M. Chow, Chi-Lung Lin, Tarkan Calisaneller, Klaus F. Ley, Neal F. Kassell, Kevin S. Lee

    CEREBRAL VASOSPASM IS a common, formidable, and potentially devastating complication in patients who have sustained subarachnoid hemorrhage (SAH). Despite intensive research efforts, cerebral vasospasm remains incompletely understood from both the pathogenic and therapeutic perspectives. At present, no consistently efficacious and ubiquitously applied preventive and therapeutic measures are available in clinical practice. Recently, convincing data have implicated a role of inflammation in the development and maintenance of cerebral vasospasm. A burgeoning (although incomplete) body of evidence suggests that various constituents of the inflammatory response, including adhesion molecules, cytokines, leukocytes, immunoglobulins, and complement, may be critical in the pathogenesis of cerebral vasospasm. Recent studies attempting to dissect the cellular and molecular basis of the inflammatory response accompanying SAH and cerebral vasospasm have provided a promising groundwork for future studies. It is plausible that the inflammatory response may indeed represent a critical common pathway in the pathogenesis of cerebral vasospasm pursuant to SAH. Investigations into the nature of the inflammatory response accompanying SAH are needed to elucidate the precise role(s) of inflammatory events in SAH-induced pathologies.


  • Chronic Endothelin Antagonism Restores Cerebrovascular Function in Diabetes

    by Aaron S. Dumont, Randall J. Dumont, John H. McNeill, Neal F. Kassell, Garnette R. Sutherland, Subodh Verma

    OBJECTIVE. Diabetes profoundly alters vascular function and is a risk factor for cerebrovascular disease. Diabetes increases myogenic tone and decreases


  • Will improved understanding of the pathophysiological mechanisms involved in acute spinal cord injury improve the potential for therapeutic intervention?

    by Aaron S. Dumont, Randall J. Dumont, Rod J. Oskouian

    At the dawning of the present decade, deemed appropriately the Decade of the Spine, acute spinal cord injury lingers as a formidable disorder affecting society. The enormous physical, emotional and socioeconomic impact of acute spinal cord injury on society is well known. Consequently, intensive clinical and laboratory research efforts have focused on furthering contemporary understanding of the mechanisms involved in primary and secondary injury following spinal cord injury. Additionally, research has been devoted to investigations concerning the treatment of acute spinal cord injury using a myriad of strategies, some of which involve rational targeting of known pathophysiological mechanisms. A recent surge of studies endeavoring to dissect the cellular and molecular mechanisms involved in the development and perpetuation of acute spinal cord injury appear particularly promising as a basis for identifying candidate pathways of injury for therapeutic manipulation. Meritorious investigations examining changes in gene expression, especially pertaining to pathways of cell death and inflammation, are increasingly reported. Molecular therapies harnessing knowledge gleaned from the aforementioned groundwork, including stem cell transplantation, likely represent the future direction of treatment for acute spinal cord injury. The Decade of the Spine is poised to be a phase of advancement in the treatment of acute spinal cord injury and the importance of further elucidation of underlying pathophysiological mechanisms to targeted, rational therapy will likely become clearly evident.


  • Surgical management of unruptured basilar artery bifurcation aneurysms

    by Aaron S. Dumont, Rod J. Oskouian, Michael M. Chow, Neal F. Kassell

    The basilar artery (BA) bifurcation is the most common site for aneurysms arising from the posterior circulation. Their inhospitable location, nested within the narrow confines of the interpeduncular fossa anterior to the brainstem, coupled with the rich network of adjacent critical thalamoperforating arteries irrigating the midbrain and thalamus, pose difficult anatomical obstacles for the surgeon. The age old adage that the only cure for intracranial aneurysms remains exclusion from circulation before rupture still holds true. Although management of unruptured aneurysms in general is still controversial, unruptured aneurysms of the BA bifurcation can be treated surgically with acceptable rates of morbidity. The clinician must gather and weigh all clinical, pathological, and radiological data when formulating recommendations for the individual patient. In the present report the authors describe their current technique for the surgical management of unruptured BA bifurcation aneurysms; this represents the culmination of the senior author's (N.K.) experience in the management of both ruptured and unruptured BA bifurcation aneurysms. A modified, right-sided subtemporal transtentorial approach has been adopted in all cases of isolated unruptured BA bifurcation aneurysms. Technical nuances are described.


  • Improvement of endothelial function in insulin-resistant carotid arteries treated with pravastatin

    by Aaron S. Dumont, M. Eric Hyndman, Randall J. Dumont, Paul M. Fedak, Neal F. Kassell, Garnette R. Sutherland, Subodh Verma

    Object. Insulin resistance and hypertension are independent risk factors for stroke. Endothelial dysfunction in response to risk factors and carotid artery (CA) disease are important in the pathogenesis of stroke. Pravastatin may have cholesterol-independent pleiotropic effects. In the present study the authors examined the effects of short-course pravastatin treatment on endothelial function in CAs obtained in control and insulin-resistant rats with fructose-induced hypertension. Methods. Thirty rats were divided into two experimental groups, in which 14 were fed a regular diet and 16 were fed a fructose-enriched diet for 3 weeks. The rats were then divided into four groups: control, pravastatin-treated control, fructose-fed, and pravastatin-treated fructose-fed. Pravastatin was administered (20 mg/kg/day) for 2 weeks. Excretion of the urinary nitric oxide (NO) metabolite nitrite (NO2−) was also assayed. The CAs from all rats were subsequently removed and assessed for endothelium-dependent and -independent vascular reactivity in vitro. The rats in the fructose-fed group were insulin resistant, hyperinsulinemic, and hypertensive relative to the rats in the control and pravastatin-treated control groups and exhibited diminished endothelium-dependent vasomotion and urinary NO2− excretion (p < 0.05), with preserved endothelium-independent vasomotion. Strikingly, pravastatin treatment restored endothelium-dependent vasomotion and urinary NO2− excretion in rats in the fructose-fed pravastatin-treated relative to the fructose-fed group (p < 0.05). Conclusions. The authors report, for the first time, that pravastatin restores endothelial function in CAs from insulin-resistant rats with fructose-induced hypertension. These beneficial effects were ascribed to direct, cholesterol-independent vascular effects of pravastatin and are likely the result of augmentation of NO production. These data provide impetus for further investigation of nonlipid-lowering indications for pravastatin therapy in the prevention and treatment of CA disease.


  • Augmentation of endothelial function by endothelin antagonism in human saphenous vein conduits

    by Aaron S. Dumont, Fina Lovren, John H. McNeill, Garnette R. Sutherland, Christopher R. Triggle, Todd J. Anderson, Subodh Verma

    Object. Cerebral revascularization with saphenous vein (SV) conduits is used in the management of hard-to-treat lesions that require deliberate arterial occlusion and in selected patients with occlusive vascular disease. Endothelial dysfunction is thought to contribute to acute perioperative vasospasm and chronic graft atherosclerosis. In the present study the authors examined the contribution of the potent vasoconstrictor endothelin-1 (ET-1) to endothelial dysfunction in human SVs. Methods. The effects of an ETA/B receptor antagonist (bosentan), an ETA receptor antagonist (BQ-123), and an ETB receptor antagonist (BQ-788) on in vitro endothelium-dependent and -independent responses were studied in human SVs. Vascular segments were obtained in 34 patients who had undergone revascularization procedures, and isometric dose—response curves (DRCs) were constructed using the isolated tissue bath procedure as follows: 1) cumulative DRCs to norepinephrine; and 2) DRCs to acetylcholine (ACh) and sodium nitroprussi...